Skip to Content
Søk Menu

ASCO20: Patients with non metastatic castration resistant prostate cancer

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Relatert innhold

Get in the Perineum! – Refinement of Prostate Biopsy Technique for Patient Safety and Antibiotic Stewardship

/ Lars Boesen
Prostatakreft
Jerome Leow

PSMA PET Staging Significantly Improves Prognosis in Pelvic Node-Positive Prostate Cancer

/ Boon Yang Jerome Leow
Prostatakreft Play the Video 07:19
Thorgerdur Palsdottir

The Capio Model for Prostate Cancer Diagnostics

/ Thorgerdur Palsdottir
ASCO24Prostatakreft Play the Video 8:20
Marc Eid og Karl Semaan

Cancer Epigenomics Improve the Overall Survival and the Quality of Life

/ Marc Eid / Karl Semaan
ASCOGU24Prostatakreft Play the Video 1:31

ASCO GU 2024: A Combination of Cabozantinib and Atezolizumab is Promising for Advanced Prostate Cancer Patients with Poor Prognoses

/ Sofie Pohl
ASCOGU24Prostatakreft
Maha H. A. Hussain

Data from the BRCAAway Study Confirms Better PFS & Efficacy with a Combination of Olaparib + Abiraterone Prednisone

/ Maha H. A. Hussain
ASCOGU24Prostatakreft Play the Video 03:10
Neeraj Agarwal

CONTACT-2: Cabozantinib + Atezolizumab for Patients with Metastatic Castration-Resistant Prostate Cancer

/ Neeraj Agarwal
ASCOGU24Prostatakreft Play the Video 05:04
Sophie D. Fosså

Self-Reported Health as a Prognostic Factor in Curative Treatment of Prostate Cancer

/ Sophie D. Fosså
OnkologiskForum23Prostatakreft Play the Video 5:48
Daniel Heinrich

Utvalgte ESMO 2023 Høydepunkter: Prostatakreft

/ Daniel Heinrich
ESMO23Prostatakreft Play the Video 3:31
Back to top